Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a minor update to the page version.SummaryDifference0.0%

- Check14 days agoChange Detected- The page footer shows Revision: v3.6.2, indicating an updated template/version is in use. The underlying study information and UI content remain the same, with no changes to study details or data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page gains a recruitment status note stating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated revision label. It also standardizes the Intervention/Treatment label by removing the space around the slash.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, replacing the previous revision tag. This reflects a new page version for internal tracking.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a new build/version of the page's content rather than changes to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a new page build. This change does not modify any study data, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.